Ive copied some bits of it below. Interesting read... They dont recommend it. These are my concerns as well and thats why I sold out early this year.
There are other red flags, too: the company's clean balance sheet was achieved with a $120m capital raising last year, but it was only open to institutional investors - retail shareholders were heavily diluted, so the company doesn't pass our 'shareholder-friendly' test. Then there's chief executive Michael Perry's 2020 pay cheque of US$17m in cash and stock grants, with a further US$8m going to five senior personnel. When management takes home more than their company earns in revenue, our eyebrows are firmly raised.
- Forums
- ASX - By Stock
- AVH
- AVH on NASDAQ
AVH on NASDAQ, page-937
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.72 |
Change
0.090(3.42%) |
Mkt cap ! $186.5M |
Open | High | Low | Value | Volume |
$2.74 | $2.77 | $2.66 | $887.5K | 325.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 631 | $2.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.73 | 900 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 203 | 2.720 |
4 | 9889 | 2.710 |
5 | 38789 | 2.700 |
1 | 3000 | 2.690 |
2 | 32312 | 2.680 |
Price($) | Vol. | No. |
---|---|---|
2.730 | 900 | 1 |
2.740 | 2332 | 4 |
2.750 | 6162 | 5 |
2.760 | 8852 | 4 |
2.770 | 14694 | 3 |
Last trade - 14.14pm 15/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online